CRSP logo

CRISPR Therapeutics AG (CRSP) Net income

annual net income:

-$366.25M-$212.64M(-138.43%)
December 31, 2024

Summary

  • As of today (June 29, 2025), CRSP annual net profit is -$366.25 million, with the most recent change of -$212.64 million (-138.43%) on December 31, 2024.
  • During the last 3 years, CRSP annual net income has fallen by -$743.91 million (-196.98%).
  • CRSP annual net income is now -196.98% below its all-time high of $377.66 million, reached on December 31, 2021.

Performance

CRSP Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

quarterly net income:

-$136.00M-$98.69M(-264.49%)
March 31, 2025

Summary

  • As of today (June 29, 2025), CRSP quarterly net profit is -$136.00 million, with the most recent change of -$98.69 million (-264.49%) on March 31, 2025.
  • Over the past year, CRSP quarterly net income has dropped by -$19.41 million (-16.64%).
  • CRSP quarterly net income is now -117.91% below its all-time high of $759.23 million, reached on June 30, 2021.

Performance

CRSP quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

TTM net income:

-$385.66M-$19.41M(-5.30%)
March 31, 2025

Summary

  • As of today (June 29, 2025), CRSP TTM net profit is -$385.66 million, with the most recent change of -$19.41 million (-5.30%) on March 31, 2025.
  • Over the past year, CRSP TTM net income has dropped by -$168.52 million (-77.61%).
  • CRSP TTM net income is now -186.36% below its all-time high of $446.58 million, reached on June 30, 2021.

Performance

CRSP TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCRSPincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

CRSP Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-138.4%-16.6%-77.6%
3 y3 years-197.0%+24.1%-223.8%
5 y5 years-647.8%-95.0%-947.0%

CRSP Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-197.0%+43.7%-252.2%+26.8%-223.8%+43.4%
5 y5-year-197.0%+43.7%-117.9%+26.8%-186.4%+43.4%
alltimeall time-197.0%+43.7%-117.9%+26.8%-186.4%+43.4%

CRSP Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$136.00M(+264.5%)
-$385.66M(+5.3%)
Dec 2024
-$366.25M(+138.4%)
-$37.31M(-56.6%)
-$366.25M(+52.9%)
Sep 2024
-
-$85.94M(-32.0%)
-$239.59M(-9.9%)
Jun 2024
-
-$126.41M(+8.4%)
-$265.80M(+22.4%)
Mar 2024
-
-$116.59M(-230.5%)
-$217.14M(+41.4%)
Dec 2023
-$153.61M(-76.4%)
$89.35M(-179.7%)
-$153.61M(-56.5%)
Sep 2023
-
-$112.15M(+44.3%)
-$353.53M(-15.0%)
Jun 2023
-
-$77.74M(+46.5%)
-$415.93M(-20.6%)
Mar 2023
-
-$53.06M(-52.0%)
-$524.02M(-19.4%)
Dec 2022
-$650.17M(-272.2%)
-$110.58M(-36.7%)
-$650.17M(-4.5%)
Sep 2022
-
-$174.55M(-6.1%)
-$680.85M(+7.5%)
Jun 2022
-
-$185.83M(+3.7%)
-$633.45M(-303.3%)
Mar 2022
-
-$179.22M(+26.9%)
$311.61M(-17.5%)
Dec 2021
$377.66M(-208.3%)
-$141.25M(+11.1%)
$377.66M(-8.3%)
Sep 2021
-
-$127.15M(-116.7%)
$411.87M(-7.8%)
Jun 2021
-
$759.23M(-770.9%)
$446.58M(-213.8%)
Mar 2021
-
-$113.16M(+5.7%)
-$392.30M(+12.4%)
Dec 2020
-$348.87M
-$107.04M(+15.8%)
-$348.87M(+65.1%)
Sep 2020
-
-$92.44M(+16.0%)
-$211.28M(-1179.2%)
Jun 2020
-
-$79.66M(+14.2%)
$19.58M(-57.0%)
DateAnnualQuarterlyTTM
Mar 2020
-
-$69.73M(-328.3%)
$45.53M(-31.9%)
Dec 2019
$66.86M(-140.5%)
$30.54M(-77.9%)
$66.86M(-693.0%)
Sep 2019
-
$138.42M(-357.8%)
-$11.27M(-94.4%)
Jun 2019
-
-$53.70M(+10.9%)
-$200.41M(+8.3%)
Mar 2019
-
-$48.41M(+1.7%)
-$185.09M(+12.2%)
Dec 2018
-$164.98M(+141.4%)
-$47.59M(-6.2%)
-$164.98M(+40.7%)
Sep 2018
-
-$50.71M(+32.1%)
-$117.25M(+28.5%)
Jun 2018
-
-$38.38M(+35.6%)
-$91.25M(+21.4%)
Mar 2018
-
-$28.30M(<-9900.0%)
-$75.18M(+10.0%)
Dec 2017
-$68.36M(+194.6%)
$141.00K(-100.6%)
-$68.36M(+33.0%)
Sep 2017
-
-$24.71M(+10.7%)
-$51.40M(+24.2%)
Jun 2017
-
-$22.32M(+3.9%)
-$41.39M(+14.2%)
Mar 2017
-
-$21.48M(-225.6%)
-$36.23M(+56.2%)
Dec 2016
-$23.20M(-10.2%)
$17.10M(-216.4%)
-$23.20M(-55.9%)
Sep 2016
-
-$14.69M(-14.4%)
-$52.59M(+18.8%)
Jun 2016
-
-$17.16M(+103.3%)
-$44.25M(+63.4%)
Mar 2016
-
-$8.44M(-31.3%)
-$27.08M(+45.3%)
Dec 2015
-$25.83M(+279.8%)
-$12.29M(+93.4%)
-$18.64M(+193.4%)
Sep 2015
-
-$6.35M
-$6.35M
Dec 2014
-$6.80M
-
-

FAQ

  • What is CRISPR Therapeutics AG annual net profit?
  • What is the all time high annual net income for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG annual net income year-on-year change?
  • What is CRISPR Therapeutics AG quarterly net profit?
  • What is the all time high quarterly net income for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG quarterly net income year-on-year change?
  • What is CRISPR Therapeutics AG TTM net profit?
  • What is the all time high TTM net income for CRISPR Therapeutics AG?
  • What is CRISPR Therapeutics AG TTM net income year-on-year change?

What is CRISPR Therapeutics AG annual net profit?

The current annual net income of CRSP is -$366.25M

What is the all time high annual net income for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high annual net profit is $377.66M

What is CRISPR Therapeutics AG annual net income year-on-year change?

Over the past year, CRSP annual net profit has changed by -$212.64M (-138.43%)

What is CRISPR Therapeutics AG quarterly net profit?

The current quarterly net income of CRSP is -$136.00M

What is the all time high quarterly net income for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high quarterly net profit is $759.23M

What is CRISPR Therapeutics AG quarterly net income year-on-year change?

Over the past year, CRSP quarterly net profit has changed by -$19.41M (-16.64%)

What is CRISPR Therapeutics AG TTM net profit?

The current TTM net income of CRSP is -$385.66M

What is the all time high TTM net income for CRISPR Therapeutics AG?

CRISPR Therapeutics AG all-time high TTM net profit is $446.58M

What is CRISPR Therapeutics AG TTM net income year-on-year change?

Over the past year, CRSP TTM net profit has changed by -$168.52M (-77.61%)
On this page